These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6807437)

  • 1. Rubella vaccination: persistence of antibodies for up to 16 years.
    O'Shea S; Best JM; Banatvala JE; Marshall WC; Dudgeon JA
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):253-5. PubMed ID: 6807437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and persistence of class-specific antibodies in the serum and nasopharyngeal washings of rubella vaccinees.
    O'Shea S; Best JM; Banatvala JE; Shepherd WM
    J Infect Dis; 1985 Jan; 151(1):89-98. PubMed ID: 3965597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistence of rubella antibodies after vaccination: detection after experimental challenge.
    Banatvala JE; Best JM; O'Shea S; Dudgeon JA
    Rev Infect Dis; 1985; 7 Suppl 1():S86-90. PubMed ID: 4001741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody titres in women six to eight years after the administration of RA2713 and Cendehill rubella vaccines.
    Macdonald H; Tobin JO; Cradock-Watson JE; Lomax J
    J Hyg (Lond); 1978 Jun; 80(3):337-47. PubMed ID: 649946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rubella in Orkney: seroepidemiology and vaccination.
    Moffat MA; Heywood SN; Laughton E; Gould JJ; Freestone DS
    J Hyg (Lond); 1977 Jun; 78(3):419-27. PubMed ID: 266542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rubella vaccination: antibody persistence for 14-17 years and immune status of women without and with a history of vaccination].
    Enders G; Nickerl U
    Immun Infekt; 1988 Apr; 16(2):58-64. PubMed ID: 3391631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Japanese rubella vaccine: comparative trials.
    Best JM; Banatvala JE; Bowen JM
    Br Med J; 1974 Jul; 3(5925):221-4. PubMed ID: 4602899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rubella viraemia and antibody responses after rubella vaccination and reimmunization.
    Balfour HH; Groth KE; Edelman CK; Amren DP; Best JM; Banatvala JE
    Lancet; 1981 May; 1(8229):1078-80. PubMed ID: 6112449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunoglobulin M response to rubella vaccine in young adult women.
    Mortimer PP; Edwards JM; Porter AD; Tedder RS; Haslehurst J
    J Hyg (Lond); 1984 Jun; 92(3):277-83. PubMed ID: 6376624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing.
    Hedman K; Hietala J; Tiilikainen A; Hartikainen-Sorri AL; Räihä K; Suni J; Väänänen P; Pietiläinen M
    J Med Virol; 1989 Apr; 27(4):293-8. PubMed ID: 2656909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella immunity by four different techniques: results of challenge studies.
    Best JM; Harcourt GC; Druce A; Palmer SJ; O'Shea S; Banatvala JE
    J Med Virol; 1980; 5(3):239-47. PubMed ID: 7014779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rubella screening and immunisation of schoolgirls: results six to seven years after vaccination.
    Zealley H; Edmond E
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):382-4. PubMed ID: 6800467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of rubella-specific serum IgG and IgA and nasopharyngeal IgA responses using a radioactive single radial immunodiffusion technique.
    Al-Nakib W; Best JM; Banatvala JE
    Clin Exp Immunol; 1975 Nov; 22(2):293-301. PubMed ID: 813933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of immunity after rubella vaccination: a long-term study in Switzerland.
    Just M; Just V; Berger R; Burkhardt F; Schilt U
    Rev Infect Dis; 1985; 7 Suppl 1():S91-4. PubMed ID: 4001742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low level immunity on response to live rubella virus vaccine.
    Väänänen P; Mäkelä P; Vaheri A
    Vaccine; 1986 Mar; 4(1):5-8. PubMed ID: 3962450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of antibody titers after vaccination with rubella virus vaccine ("Cendehill" strain).
    Peetermans J; du Pan RM; Huygelen C
    Dev Biol Stand; 1979; 43():361-5. PubMed ID: 520683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of antibody 10 years after vaccination with Wistar RA27/3 strain live attenuated rubella vaccine.
    Hillary IB; Griffith AH
    Br Med J; 1980 Jun; 280(6231):1580-1. PubMed ID: 7427177
    [No Abstract]   [Full Text] [Related]  

  • 18. Persistence of antibody induced by rubella vaccine (Wistar RA 27/3 strain) after six years.
    Hillary IB; Freestone DS
    J Hyg (Lond); 1975 Dec; 75(3):407-11. PubMed ID: 1059708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubella-specific serum and nasopharygeal immunoglobulin responses following naturally acquired and vaccine-induced infection. Prolonged persistence of virus-specific IgM.
    Al-Nakib W; Best JM; Banatvala JE
    Lancet; 1975 Jan; 1(7900):182-5. PubMed ID: 47417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines.
    Wang SS; Han YR; Su WN; Chen J; Zhao K
    Vaccine; 1984 Dec; 2(4):277-80. PubMed ID: 6531968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.